#prostatecancer نتائج البحث

There are some things that should never be left to chance. And #ProstateCancer is one. We need your help to fund vital research - like our recently launched £42 million TRANSFORM trial - and boost the odds of finding the disease earlier. ➡️ Donate now: bit.ly/3XhuuRm

ProstateUK's tweet image. There are some things that should never be left to chance. 

And #ProstateCancer is one.

We need your help to fund vital research - like our recently launched £42 million TRANSFORM trial - and boost the odds of finding the disease earlier.

➡️ Donate now: bit.ly/3XhuuRm

Comedy legend Peter Kay will be supporting us on his record-breaking tour 🙌 He’s announced his final arena shows, with all profit supporting 12 cancer charities, including @ProstateUK. 💙 This will make a real difference to men and their families affected by #ProstateCancer.

ProstateUK's tweet image. Comedy legend Peter Kay will be supporting us on his record-breaking tour 🙌 

He’s announced his final arena shows, with all profit supporting 12 cancer charities, including @ProstateUK.

💙 This will make a real difference to men and their families affected by #ProstateCancer.

Brilliant panel at #UromigosLive w an array of #ProstateCancer superstars, including my @cityofhope boss @TDorffOnc, @huntsmancancer program leader @neerajaiims, @ChrisSweens1, Morris & @charlesryanmd. @brian_rini doing an exceptional job navigating a complex discussion.…

montypal's tweet image. Brilliant panel at #UromigosLive w an array of #ProstateCancer superstars, including my @cityofhope boss @TDorffOnc, @huntsmancancer program leader @neerajaiims, @ChrisSweens1, Morris & @charlesryanmd. @brian_rini doing an exceptional job navigating a complex discussion.…

🏆 Honored to receive the Best Scientific Paper Award – CBU 2025 for our study validating the CAPRA score after HIFU. Grateful to my co-authors, mentors @StenioZequi, @LondonProstate1, and my family for their constant support. #Urology #ProstateCancer #HIFU #CAPRA #CBU2025

ederbrazaojr's tweet image. 🏆 Honored to receive the Best Scientific Paper Award – CBU 2025 for our study validating the CAPRA score after HIFU.

Grateful to my co-authors, mentors @StenioZequi, @LondonProstate1, and my family for their constant support.

#Urology #ProstateCancer #HIFU #CAPRA #CBU2025

Excellent example of #prostatecancer with coarse eosinophilic granules (so-called 'Paneth cell-like' change; **unlike Paneth cells of GI tract, these cells DO NOT contain lysozyme and DO express neuroendocrine markers) - can be seen in both primary & post-treatment specimens👇🏻

rovingatuscap's tweet image. Excellent example of #prostatecancer with coarse eosinophilic granules (so-called 'Paneth cell-like' change; **unlike Paneth cells of GI tract, these cells DO NOT contain lysozyme and DO express neuroendocrine markers) - can be seen in both primary & post-treatment specimens👇🏻

The British Association of Surgical Oncology @baso commends Lord David Cameron for going public about his prostate cancer diagnosis and treatment journey. #ProstateCancer is the most common cancer in men in the UK, with around 55,000 new cases each year. Public figures speaking…

BASO_ACS's tweet image. The British Association of Surgical Oncology @baso commends Lord David Cameron for going public about his prostate cancer diagnosis and treatment journey.

#ProstateCancer is the most common cancer in men in the UK, with around 55,000 new cases each year. 
Public figures speaking…

The second #ProstateCancer session at #UromigosLive 2025 was a discussion about the approach to mHSPC, building on ADT+ARPI and debating the inclusion of a third agent including docetaxel, PARPi, radioligand or AKT inhibition. Uromigos.org for full videos with slides.…

Uromigos's tweet image. The second #ProstateCancer session at #UromigosLive 2025 was a discussion about the approach to mHSPC, building on ADT+ARPI and debating the inclusion of a third agent including docetaxel, PARPi, radioligand or AKT inhibition. Uromigos.org for full videos with slides.…

New #MetaAnalysis on metastatic hormone-sensitive #ProstateCancer (mHSPC): 👍Among 12,668 pts, triplet therapy (ARPI + Docetaxel + ADT) improves OS in synchronous high-volume disease. 👍For all other subgroups, ARPI + ADT is best. 👎No role for Docetaxel + ADT alone.…

yekeduz_emre's tweet image. New #MetaAnalysis on metastatic hormone-sensitive #ProstateCancer (mHSPC):
👍Among 12,668 pts, triplet therapy (ARPI + Docetaxel + ADT) improves OS in synchronous high-volume disease.
👍For all other subgroups, ARPI + ADT is best.
👎No role for Docetaxel + ADT alone.…

Free tonight? In the Los Angeles area? Please come join our @cityofhope GU team leader @TDorffOnc for a terrific @OncLiveSOSS in Arcadia, CA covering NMIBC (@WesleyYipMD), #kidneycancer (@charlesbnguyen) & #prostatecancer (@arafflemd). Monday 11/17 at 5:30 pm - hope to see you…

montypal's tweet image. Free tonight? In the Los Angeles area? Please come join our @cityofhope GU team leader @TDorffOnc for a terrific @OncLiveSOSS in Arcadia, CA covering NMIBC (@WesleyYipMD), #kidneycancer (@charlesbnguyen) & #prostatecancer (@arafflemd). Monday 11/17 at 5:30 pm - hope to see you…

Predicting the indication for adjuvant radiation therapy according to EAU guidelines among patients with high-risk prostate cancer: a novel multivariable model nature.com/articles/s4139… In a retrospective study of 5,691 high-risk #ProstateCancer patients treated at a high-volume…

mirrorsmed's tweet image. Predicting the indication for adjuvant radiation therapy according to EAU guidelines among patients with high-risk prostate cancer: a novel multivariable model

 nature.com/articles/s4139…

In a retrospective study of 5,691 high-risk #ProstateCancer patients treated at a high-volume…

3 days left of @movember. Raising money for men who are dying too young. £690 raised so far this month to help men suffering from prostate cancer, testicular cancer and mental health. #movember #ProstateCancer

nattasswfc's tweet image. 3 days left of @movember. Raising money for men who are dying too young. £690 raised so far this month to help men suffering from prostate cancer, testicular cancer and mental health. #movember #ProstateCancer

177Lu-Prostate-Specific Membrane Antigen Neoadjuvant to Stereotactic Ablative Radiotherapy for Oligorecurrent #ProstateCancer (LUNAR) ascopubs.org/doi/10.1200/JC… The phase II LUNAR trial (NCT05496959) evaluated whether adding neoadjuvant PSMA-targeted radioligand therapy…

APCCC_Lugano's tweet image. 177Lu-Prostate-Specific Membrane Antigen Neoadjuvant to Stereotactic Ablative Radiotherapy for Oligorecurrent #ProstateCancer (LUNAR)

ascopubs.org/doi/10.1200/JC…

The phase II LUNAR trial (NCT05496959) evaluated whether adding neoadjuvant PSMA-targeted radioligand therapy…

Meet #CamPROBE from @medovate a game-changer in prostate biopsies🔬 ✓ Lower infection risk ✓ Less invasive ✓ Simple to use ✓ Cost-effective Experience safer, more comfortable patient outcomes with our innovative transperineal biopsy device #ProstateDiagnostics #prostatecancer


1/ 🚨 Pleased to share that our latest manuscript is out now in @EUplatinum! Baseline and on-treatment #ctDNA biomarkers in men with advanced #ProstateCancer treated with #LuPSMA. bit.ly/4nzJRyV Thanks to @LouiseKostos Heidi Fettke @PeterMacCC

AzadOncology's tweet image. 1/ 🚨 Pleased to share that our latest manuscript is out now in @EUplatinum!

Baseline and on-treatment #ctDNA biomarkers in men with advanced #ProstateCancer treated with #LuPSMA. 

bit.ly/4nzJRyV 

Thanks to @LouiseKostos Heidi Fettke @PeterMacCC

AI–assisted lesion-tracking analysis of PSMA PET is prognostic for overall survival in patients with mCRPC undergoing PSMA radiopharmaceutical therapy. ow.ly/JOvo50XqIMQ #NuclearMedicine #RPTherapy #ProstateCancer @VMurthymed @CalaisJeremie @DrAGafita

JournalofNucMed's tweet image. AI–assisted lesion-tracking analysis of PSMA PET is prognostic for overall survival in patients with mCRPC undergoing PSMA radiopharmaceutical therapy. ow.ly/JOvo50XqIMQ 

#NuclearMedicine #RPTherapy #ProstateCancer @VMurthymed @CalaisJeremie @DrAGafita

#UPDATE : Former UK Prime Minister David Cameron has revealed that he received treatment for prostate cancer. He shared the news publicly as part of a growing call for a national targeted screening programme. #DavidCameron #ProstateCancer #HealthNews #UKPolitics #Cancer

upuknews1's tweet image. #UPDATE : Former UK Prime Minister David Cameron has revealed that he received treatment for prostate cancer. He shared the news publicly as part of a growing call for a national targeted screening programme.

#DavidCameron #ProstateCancer #HealthNews #UKPolitics #Cancer
upuknews1's tweet image. #UPDATE : Former UK Prime Minister David Cameron has revealed that he received treatment for prostate cancer. He shared the news publicly as part of a growing call for a national targeted screening programme.

#DavidCameron #ProstateCancer #HealthNews #UKPolitics #Cancer
upuknews1's tweet image. #UPDATE : Former UK Prime Minister David Cameron has revealed that he received treatment for prostate cancer. He shared the news publicly as part of a growing call for a national targeted screening programme.

#DavidCameron #ProstateCancer #HealthNews #UKPolitics #Cancer

🇫🇷 Congratulations to the French Association of Urology for incorporating #bpMRI into their latest #prostatecancer guidelines, supported by #evidence from #PRIME Great to see the impact of international collaboration across France, the UK and beyond ✨ Links below 👇 #UroSoMe

COMPASSurology's tweet image. 🇫🇷 Congratulations to the French Association of Urology for incorporating #bpMRI into their latest #prostatecancer guidelines, supported by #evidence from #PRIME

Great to see the impact of international collaboration across France, the UK and beyond ✨

Links below 👇

#UroSoMe
COMPASSurology's tweet image. 🇫🇷 Congratulations to the French Association of Urology for incorporating #bpMRI into their latest #prostatecancer guidelines, supported by #evidence from #PRIME

Great to see the impact of international collaboration across France, the UK and beyond ✨

Links below 👇

#UroSoMe
COMPASSurology's tweet image. 🇫🇷 Congratulations to the French Association of Urology for incorporating #bpMRI into their latest #prostatecancer guidelines, supported by #evidence from #PRIME

Great to see the impact of international collaboration across France, the UK and beyond ✨

Links below 👇

#UroSoMe

Testosterone replacement therapy following definitive treatment for #prostatecancer: a scoping review of safety and efficacy👉 rdcu.be/eScnq @PeteGrice @MoheeAmar @TheodoraStas @IPearce82 @VaibhavModgil @ManchesterAndro

yoursexmedjour's tweet image. Testosterone replacement therapy following definitive treatment for #prostatecancer: a scoping review of safety and efficacy👉 rdcu.be/eScnq

@PeteGrice @MoheeAmar @TheodoraStas @IPearce82 @VaibhavModgil @ManchesterAndro

Prostate cancer is rising in India, with cases now appearing in men as young as 35 to 50. Poor lifestyle, obesity, inactivity, and inherited gene mutations are key factors. Watch for symptoms and consult a urologist early if needed. #ProstateCancer #MensHealth


Following on from our charity promotion last week, we are pleased to state we have donated the funds raised to Prostate Cancer UK #InternationalMensDay #ProstateCancer #MensHealth @ProstateUK

HambDane's tweet image. Following on from our charity promotion last week, we are pleased to state we have donated the funds raised to Prostate Cancer UK

#InternationalMensDay #ProstateCancer #MensHealth @ProstateUK

Tame the fire! Prostate cancer is a silent fire, slow, unnoticed, and often ignored… until it becomes too big to control. #CancerCare #ProstateCancer #DrVijayAnandReddy #ApolloCancerInstitute #OncologyUpdate #Hyderabad


व्हिटॅमिन डीच्या कमतरतेमुळे पुरुषांना जडतोय कॅन्सर? 'या' लक्षणांकडे दुर्लक्ष करणे धोक्याचे; डॉक्टर्स काय सांगतात? loksatta.com/explained/low-… #VitaminDDeficiency #ProstateCancer #CancerInMen


💊 Prostate Cancer Breakthrough: A new PSMA targeted radioligand therapy shows higher survival in metastatic prostate cancer compared to standard treatments. Precision radiation hits only the tumor. #CancerResearch #Oncology #ProstateCancer #RadioligandTherapy @OncoAlert

NeerajResearch's tweet image. 💊 Prostate Cancer Breakthrough:
A new PSMA targeted radioligand therapy shows higher survival in metastatic prostate cancer compared to standard treatments.
Precision radiation hits only the tumor.
#CancerResearch #Oncology #ProstateCancer #RadioligandTherapy @OncoAlert

Editor @msstaceyerin revisits a popular topic to see whether #regenerativemedicine is advancing #ProstateCancer research. Sprouting a ’stache is fun… but sprouting hope is even better. Comb through the full story signalsblog.ca/right-turn-bey… #Movember #MensHealth #CancerResearch

Signalsblogs's tweet image. Editor @msstaceyerin revisits a popular topic to see whether #regenerativemedicine is advancing  #ProstateCancer research. Sprouting a ’stache is fun… but sprouting hope is even better. Comb through the full story signalsblog.ca/right-turn-bey… #Movember #MensHealth #CancerResearch

Not a single #Thanksgiving has gone by over the past decade when I haven’t been grateful for having my boss/ally/friend @TDorffOnc at @cityofhope. Beyond the incredible strides she has made in #immunotherapy for #prostatecancer, she has led our growing group with integrity,…

montypal's tweet image. Not a single #Thanksgiving has gone by over the past decade when I haven’t been grateful for having my boss/ally/friend @TDorffOnc at @cityofhope. Beyond the incredible strides she has made in #immunotherapy for #prostatecancer, she has led our growing group with integrity,…

In the latest episode of On the Edge of Breakthrough, @montypal and @TDorffOnc discuss her pioneering work in immunotherapy for prostate cancer, the importance of collaborative team-science, and so much more! Watch and subscribe: bit.ly/3M0bK6l



🇫🇷 Congratulations to the French Association of Urology for incorporating #bpMRI into their latest #prostatecancer guidelines, supported by #evidence from #PRIME Great to see the impact of international collaboration across France, the UK and beyond ✨ Links below 👇 #UroSoMe

COMPASSurology's tweet image. 🇫🇷 Congratulations to the French Association of Urology for incorporating #bpMRI into their latest #prostatecancer guidelines, supported by #evidence from #PRIME

Great to see the impact of international collaboration across France, the UK and beyond ✨

Links below 👇

#UroSoMe
COMPASSurology's tweet image. 🇫🇷 Congratulations to the French Association of Urology for incorporating #bpMRI into their latest #prostatecancer guidelines, supported by #evidence from #PRIME

Great to see the impact of international collaboration across France, the UK and beyond ✨

Links below 👇

#UroSoMe
COMPASSurology's tweet image. 🇫🇷 Congratulations to the French Association of Urology for incorporating #bpMRI into their latest #prostatecancer guidelines, supported by #evidence from #PRIME

Great to see the impact of international collaboration across France, the UK and beyond ✨

Links below 👇

#UroSoMe

What’s missing in current clinical guidelines on prostate cancer that every new specialist should know? @CaPsurvivorship shares her opinion at #ESMO25, including the importance of mitigating the risk of comorbidities #MedX #ProstateCancer #Movember ow.ly/ap8W50XyGu2

Medthority's tweet image. What’s missing in current clinical guidelines on prostate cancer that every new specialist should know? @CaPsurvivorship shares her opinion at #ESMO25, including the importance of mitigating the risk of comorbidities #MedX #ProstateCancer #Movember 

ow.ly/ap8W50XyGu2

Looking to speak to black men about #prostatecancer awareness and screening in the UK - for a sensitive Men's Health magazine piece. Can be anon. Please email [email protected] #journorequest #blacktwitter


Predicting the indication for adjuvant radiation therapy according to EAU guidelines among patients with high-risk prostate cancer: a novel multivariable model nature.com/articles/s4139… In a retrospective study of 5,691 high-risk #ProstateCancer patients treated at a high-volume…

mirrorsmed's tweet image. Predicting the indication for adjuvant radiation therapy according to EAU guidelines among patients with high-risk prostate cancer: a novel multivariable model

 nature.com/articles/s4139…

In a retrospective study of 5,691 high-risk #ProstateCancer patients treated at a high-volume…

New therapeutic strategies show promise against a hard-to-treat prostate cancer. ow.ly/r3NC50XyCn3 #ProstateCancer #CancerResearch #Oncology #CancerAwareness #CancerTreatment

hospitalnewscom's tweet image. New therapeutic strategies show promise against a hard-to-treat prostate cancer.
ow.ly/r3NC50XyCn3
#ProstateCancer #CancerResearch #Oncology #CancerAwareness #CancerTreatment

It's absolutely right the the UK National Screening Committee get hold of prostate cancer screening & implement it ASAP. The SoS for Health @wesstreeting @DHSCgovuk @NHSuk need to push hard for this. #prostatecancer


📢 There’s still time to sign up! Men across Greater Manchester are invited to our online prostate cancer focus group. 🗓 Fri 28 Nov 2025 🕚 11:30am 💻 Microsoft Teams 👉 Call 0161 253 6300 or email [email protected] #prostatecancer

Healthwatchbury's tweet image. 📢 There’s still time to sign up! 
Men across Greater Manchester are invited to our online prostate cancer focus group.

🗓 Fri 28 Nov 2025 🕚 11:30am 💻 Microsoft Teams

👉 Call 0161 253 6300 or email info@healthwatchbury.co.uk #prostatecancer

📝Access mCRPC treatment guidance in seconds with @ONCOassist This tool presents efficacy data from recent trials of novel treatments for patients with mCRPC. #mCRPC #ProstateCancer #OncologyTools #CancerCare #ClinicalOncology #DigitalHealth #OncologyApp


The second #ProstateCancer session at #UromigosLive 2025 was a discussion about the approach to mHSPC, building on ADT+ARPI and debating the inclusion of a third agent including docetaxel, PARPi, radioligand or AKT inhibition. Uromigos.org for full videos with slides.…

Uromigos's tweet image. The second #ProstateCancer session at #UromigosLive 2025 was a discussion about the approach to mHSPC, building on ADT+ARPI and debating the inclusion of a third agent including docetaxel, PARPi, radioligand or AKT inhibition. Uromigos.org for full videos with slides.…

Know your risks! 🚨 Prostate cancer is the most common cancer among men in Uganda & a leading cause of cancer-related deaths worldwide. Early detection saves lives! #Men 45+ should get annual screenings. Healthy lifestyle = lower risk. #ProstateCancer #Movember #Uganda

UgandaCancerIns's tweet image. Know your risks! 🚨 Prostate cancer is the most common cancer among men in Uganda & a leading cause of cancer-related deaths worldwide. Early detection saves lives! 
#Men 45+ should get annual screenings. Healthy lifestyle = lower risk. #ProstateCancer #Movember #Uganda…

🏆 Honored to receive the Best Scientific Paper Award – CBU 2025 for our study validating the CAPRA score after HIFU. Grateful to my co-authors, mentors @StenioZequi, @LondonProstate1, and my family for their constant support. #Urology #ProstateCancer #HIFU #CAPRA #CBU2025

ederbrazaojr's tweet image. 🏆 Honored to receive the Best Scientific Paper Award – CBU 2025 for our study validating the CAPRA score after HIFU.

Grateful to my co-authors, mentors @StenioZequi, @LondonProstate1, and my family for their constant support.

#Urology #ProstateCancer #HIFU #CAPRA #CBU2025

Comedy legend Peter Kay will be supporting us on his record-breaking tour 🙌 He’s announced his final arena shows, with all profit supporting 12 cancer charities, including @ProstateUK. 💙 This will make a real difference to men and their families affected by #ProstateCancer.

ProstateUK's tweet image. Comedy legend Peter Kay will be supporting us on his record-breaking tour 🙌 

He’s announced his final arena shows, with all profit supporting 12 cancer charities, including @ProstateUK.

💙 This will make a real difference to men and their families affected by #ProstateCancer.

There are some things that should never be left to chance. And #ProstateCancer is one. We need your help to fund vital research - like our recently launched £42 million TRANSFORM trial - and boost the odds of finding the disease earlier. ➡️ Donate now: bit.ly/3XhuuRm

ProstateUK's tweet image. There are some things that should never be left to chance. 

And #ProstateCancer is one.

We need your help to fund vital research - like our recently launched £42 million TRANSFORM trial - and boost the odds of finding the disease earlier.

➡️ Donate now: bit.ly/3XhuuRm

New #MetaAnalysis on metastatic hormone-sensitive #ProstateCancer (mHSPC): 👍Among 12,668 pts, triplet therapy (ARPI + Docetaxel + ADT) improves OS in synchronous high-volume disease. 👍For all other subgroups, ARPI + ADT is best. 👎No role for Docetaxel + ADT alone.…

yekeduz_emre's tweet image. New #MetaAnalysis on metastatic hormone-sensitive #ProstateCancer (mHSPC):
👍Among 12,668 pts, triplet therapy (ARPI + Docetaxel + ADT) improves OS in synchronous high-volume disease.
👍For all other subgroups, ARPI + ADT is best.
👎No role for Docetaxel + ADT alone.…

1/ 🚨 Pleased to share that our latest manuscript is out now in @EUplatinum! Baseline and on-treatment #ctDNA biomarkers in men with advanced #ProstateCancer treated with #LuPSMA. bit.ly/4nzJRyV Thanks to @LouiseKostos Heidi Fettke @PeterMacCC

AzadOncology's tweet image. 1/ 🚨 Pleased to share that our latest manuscript is out now in @EUplatinum!

Baseline and on-treatment #ctDNA biomarkers in men with advanced #ProstateCancer treated with #LuPSMA. 

bit.ly/4nzJRyV 

Thanks to @LouiseKostos Heidi Fettke @PeterMacCC

The British Association of Surgical Oncology @baso commends Lord David Cameron for going public about his prostate cancer diagnosis and treatment journey. #ProstateCancer is the most common cancer in men in the UK, with around 55,000 new cases each year. Public figures speaking…

BASO_ACS's tweet image. The British Association of Surgical Oncology @baso commends Lord David Cameron for going public about his prostate cancer diagnosis and treatment journey.

#ProstateCancer is the most common cancer in men in the UK, with around 55,000 new cases each year. 
Public figures speaking…

John walked almost 807 miles across all 32 counties of #Ireland 🇮🇪 The journey took him 42 days, joined by friends, family, colleagues, and his four-legged friend Lobo along the way. He has raised an incredible £20,000 to help fund lifesaving #ProstateCancer research 💙

ProstateUK's tweet image. John walked almost 807 miles across all 32 counties of #Ireland 🇮🇪

The journey took him 42 days, joined by friends, family, colleagues, and his four-legged friend Lobo along the way.

He has raised an incredible £20,000 to help fund lifesaving #ProstateCancer research 💙
ProstateUK's tweet image. John walked almost 807 miles across all 32 counties of #Ireland 🇮🇪

The journey took him 42 days, joined by friends, family, colleagues, and his four-legged friend Lobo along the way.

He has raised an incredible £20,000 to help fund lifesaving #ProstateCancer research 💙
ProstateUK's tweet image. John walked almost 807 miles across all 32 counties of #Ireland 🇮🇪

The journey took him 42 days, joined by friends, family, colleagues, and his four-legged friend Lobo along the way.

He has raised an incredible £20,000 to help fund lifesaving #ProstateCancer research 💙
ProstateUK's tweet image. John walked almost 807 miles across all 32 counties of #Ireland 🇮🇪

The journey took him 42 days, joined by friends, family, colleagues, and his four-legged friend Lobo along the way.

He has raised an incredible £20,000 to help fund lifesaving #ProstateCancer research 💙

Novembre, mese della prevenzione maschile. Cerchiamo di ricordare all’opinione pubblica e ai colleghi che la radioterapia nel tumore della prostata e’ una opzione non invasiva e altrettanto efficace! #movember #ProstateCancer #radonc

alongi_filippo's tweet image. Novembre, mese della prevenzione maschile. Cerchiamo di ricordare all’opinione pubblica e ai colleghi che la radioterapia nel tumore della prostata e’ una opzione non invasiva e altrettanto efficace!  #movember #ProstateCancer #radonc
alongi_filippo's tweet image. Novembre, mese della prevenzione maschile. Cerchiamo di ricordare all’opinione pubblica e ai colleghi che la radioterapia nel tumore della prostata e’ una opzione non invasiva e altrettanto efficace!  #movember #ProstateCancer #radonc

Excellent example of #prostatecancer with coarse eosinophilic granules (so-called 'Paneth cell-like' change; **unlike Paneth cells of GI tract, these cells DO NOT contain lysozyme and DO express neuroendocrine markers) - can be seen in both primary & post-treatment specimens👇🏻

rovingatuscap's tweet image. Excellent example of #prostatecancer with coarse eosinophilic granules (so-called 'Paneth cell-like' change; **unlike Paneth cells of GI tract, these cells DO NOT contain lysozyme and DO express neuroendocrine markers) - can be seen in both primary & post-treatment specimens👇🏻

177Lu-Prostate-Specific Membrane Antigen Neoadjuvant to Stereotactic Ablative Radiotherapy for Oligorecurrent #ProstateCancer (LUNAR) ascopubs.org/doi/10.1200/JC… The phase II LUNAR trial (NCT05496959) evaluated whether adding neoadjuvant PSMA-targeted radioligand therapy…

APCCC_Lugano's tweet image. 177Lu-Prostate-Specific Membrane Antigen Neoadjuvant to Stereotactic Ablative Radiotherapy for Oligorecurrent #ProstateCancer (LUNAR)

ascopubs.org/doi/10.1200/JC…

The phase II LUNAR trial (NCT05496959) evaluated whether adding neoadjuvant PSMA-targeted radioligand therapy…

Five years on, we’re celebrating the life and legacy of our incredible ambassador and friend, #RayClemence 💙 A true @England legend, Ray faced #ProstateCancer for more than 15 years with remarkable courage and compassion, all while tirelessly supporting our work.

ProstateUK's tweet image. Five years on, we’re celebrating the life and legacy of our incredible ambassador and friend, #RayClemence 💙

A true @England legend, Ray faced #ProstateCancer for more than 15 years with remarkable courage and compassion, all while tirelessly supporting our work.

🇫🇷 Congratulations to the French Association of Urology for incorporating #bpMRI into their latest #prostatecancer guidelines, supported by #evidence from #PRIME Great to see the impact of international collaboration across France, the UK and beyond ✨ Links below 👇 #UroSoMe

COMPASSurology's tweet image. 🇫🇷 Congratulations to the French Association of Urology for incorporating #bpMRI into their latest #prostatecancer guidelines, supported by #evidence from #PRIME

Great to see the impact of international collaboration across France, the UK and beyond ✨

Links below 👇

#UroSoMe
COMPASSurology's tweet image. 🇫🇷 Congratulations to the French Association of Urology for incorporating #bpMRI into their latest #prostatecancer guidelines, supported by #evidence from #PRIME

Great to see the impact of international collaboration across France, the UK and beyond ✨

Links below 👇

#UroSoMe
COMPASSurology's tweet image. 🇫🇷 Congratulations to the French Association of Urology for incorporating #bpMRI into their latest #prostatecancer guidelines, supported by #evidence from #PRIME

Great to see the impact of international collaboration across France, the UK and beyond ✨

Links below 👇

#UroSoMe

Some of our residents and faculty member Dr. Warren are showcasing their yearly mustaches in support of #movember and #MensHealth awareness month! #ProstateCancer #TesticularCancer #MentalHealthMatters

URMCUrology's tweet image. Some of our residents and faculty member Dr. Warren are showcasing their yearly mustaches in support of #movember and #MensHealth awareness month! #ProstateCancer #TesticularCancer #MentalHealthMatters

#UPDATE : Former UK Prime Minister David Cameron has revealed that he received treatment for prostate cancer. He shared the news publicly as part of a growing call for a national targeted screening programme. #DavidCameron #ProstateCancer #HealthNews #UKPolitics #Cancer

upuknews1's tweet image. #UPDATE : Former UK Prime Minister David Cameron has revealed that he received treatment for prostate cancer. He shared the news publicly as part of a growing call for a national targeted screening programme.

#DavidCameron #ProstateCancer #HealthNews #UKPolitics #Cancer
upuknews1's tweet image. #UPDATE : Former UK Prime Minister David Cameron has revealed that he received treatment for prostate cancer. He shared the news publicly as part of a growing call for a national targeted screening programme.

#DavidCameron #ProstateCancer #HealthNews #UKPolitics #Cancer
upuknews1's tweet image. #UPDATE : Former UK Prime Minister David Cameron has revealed that he received treatment for prostate cancer. He shared the news publicly as part of a growing call for a national targeted screening programme.

#DavidCameron #ProstateCancer #HealthNews #UKPolitics #Cancer

AI–assisted lesion-tracking analysis of PSMA PET is prognostic for overall survival in patients with mCRPC undergoing PSMA radiopharmaceutical therapy. ow.ly/JOvo50XqIMQ #NuclearMedicine #RPTherapy #ProstateCancer @VMurthymed @CalaisJeremie @DrAGafita

JournalofNucMed's tweet image. AI–assisted lesion-tracking analysis of PSMA PET is prognostic for overall survival in patients with mCRPC undergoing PSMA radiopharmaceutical therapy. ow.ly/JOvo50XqIMQ 

#NuclearMedicine #RPTherapy #ProstateCancer @VMurthymed @CalaisJeremie @DrAGafita

Lots of ❓s in defining benefits of “#oligomet” or “#MDT” therapy in #ProstateCancer ❓ADT+/-ARPI? How long? ❓PFS vs Eugonadal PFS? ❓how many mets? Where? 🔑❓what imaging 🩻❓ #PSMA mets🚫🟰CT/Bone scan mets shorturl.at/n3JwU Std of Care? Or just something we can do?

Dr_RaviMadan's tweet image. Lots of ❓s in defining benefits of “#oligomet” or “#MDT” therapy in #ProstateCancer

❓ADT+/-ARPI? How long?
❓PFS vs Eugonadal PFS?
❓how many mets? Where? 
🔑❓what imaging 🩻❓
#PSMA mets🚫🟰CT/Bone scan mets
shorturl.at/n3JwU

Std of Care? Or just something we can do?

🚨Our Nov issue is live - thelancet.com/issue/S1470-20… 📊Articles: #breastcancer, #NSCLC, #prostatecancer, #melanoma 📰 Reviews: Tumour-infiltrating lymphocyte therapy in the era of genetic engineering AND AI for Response Assessment in Pediatric Neuro-Oncology (AI-RAPNO)

TheLancetOncol's tweet image. 🚨Our Nov issue is live - thelancet.com/issue/S1470-20…

📊Articles: #breastcancer, #NSCLC, #prostatecancer, #melanoma 

📰 Reviews: Tumour-infiltrating lymphocyte therapy in the era of genetic engineering AND AI for Response Assessment in Pediatric Neuro-Oncology (AI-RAPNO)

Loading...

Something went wrong.


Something went wrong.


United States Trends